Producing omega-3 polyunsaturated fatty acids: A review of sustainable sources and future trends for the EPA and DHA market

L Oliver, T Dietrich, I Marañón, MC Villarán, RJ Barrio - Resources, 2020 - mdpi.com
Omega-3 polyunsaturated fatty acids (Omega-3 PUFA) are recognized as being essential
compounds for human nutrition and health. The human body generates only low levels of …

The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication

Q Ning, D Wu, X Wang, D **, T Chen, G Chen… - Signal transduction and …, 2022 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) is a highly transmissible disease
caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that poses a …

Clinical trials on the pharmacological treatment of long COVID: A systematic review

YJ Chee, BE Fan, BE Young, R Dalan… - Journal of Medical …, 2023 - Wiley Online Library
The postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
infection (PASC), also known as post‐acute coronavirus disease 19 (COVID‐19) or the long …

Comprehensive meta-analysis of COVID-19 global metabolomics datasets

Z Pang, G Zhou, J Chong, J **a - Metabolites, 2021 - mdpi.com
The novel coronavirus SARS-CoV-2 has spread across the world since 2019, causing a
global pandemic. The pathogenesis of the viral infection and the associated clinical …

[HTML][HTML] Stimulating the resolution of inflammation through omega-3 polyunsaturated fatty acids in COVID-19: rationale for the COVID-omega-F trial

H Arnardottir, SC Pawelzik… - Frontiers in …, 2021 - frontiersin.org
Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes
coronavirus disease 2019 (COVID-19). SARS-CoV-2 triggers an immune response with …

E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing …

CN Serhan, S Libreros, R Nshimiyimana - Seminars in immunology, 2022 - Elsevier
The COVID-19 pandemic has raised international awareness of the importance of rigorous
scientific evidence and the havoc caused by uncontrolled excessive inflammation. Here we …

Long COVID and long chain fatty acids (LCFAs): Psychoneuroimmunity implication of omega-3 LCFAs in delayed consequences of COVID-19

CP Yang, CM Chang, CC Yang, CM Pariante… - Brain, Behavior, and …, 2022 - Elsevier
The global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
led to the lasting pandemic of coronavirus disease 2019 (COVID-19) and the post-acute …

Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art Review

AH Talasaz, P Sadeghipour… - Journal of the American …, 2021 - jacc.org
Abstract Coronavirus disease-2019 (COVID-19) is associated with systemic inflammation,
endothelial activation, and multiorgan manifestations. Lipid-modulating agents may be …

Effects of omega-3 polyunsaturated fatty acids and their metabolites on haemostasis—current perspectives in cardiovascular disease

J Golanski, P Szymanska, M Rozalski - International journal of molecular …, 2021 - mdpi.com
The beneficial effects of long-chain polyunsaturated omega-3 fatty acids (omega-3 PUFAs)
in cardioprotection are widely known and generally accepted. In this literature review, we …

Essential sufficiency of zinc, ω-3 polyunsaturated fatty acids, vitamin D and magnesium for prevention and treatment of COVID-19, diabetes, cardiovascular diseases …

MJ Story - Biochimie, 2021 - Elsevier
Despite the development of a number of vaccines for COVID-19, there remains a need for
prevention and treatment of the virus SARS-CoV-2 and the ensuing disease COVID-19. This …